GlaxoSmithKline and Medtronic have provided capital to Saluda Medical, a medical device maker working on a spinal cord stimulator system.

Existing investor SIG returned for the mobile communication app developer's series D round, which was led by a China Construction Bank unit.

Alphabet unit CapitalG returned for an Accel-led series D round that included Telstra, and which took the endpoint security software provider's valuation above $1bn.

GV was among the investors in a round that valued the big data-infused health insurance company, which has now raised $425m inside two years, at $1.2bn.

The Rakuten-backed ride hailing service, valued at $320m as of April 2016, is reportedly raising up to $500m in a series D round that will fund Brazilian expansion.

Hearst Entertainment has led a round that valued GV-backed music royalty collections platform Kobalt at $775m post-money.

Mitsui has led a series D round for the feedstock protein producer that included existing investor and strategic partner Cargill.

Genomic Health is among the investors in a series D round for Epic Sciences, a cancer diagnostics specialist that had previously received backing from Roche and Pfizer.